Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers

• WeTrade Group, Inc. WETG shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial intelligence.
• Cyxtera Technologies, Inc. CYXT shares climbed 71.5% to $0.0717 after dropping 12% on Tuesday.
• Blue Water Biotech, Inc. BWV gained 67% to $1.32 after the company acquired six FDA-approved drugs across various treatment areas
• WiSA Technologies, Inc. WISA shares surged 51.7% to $1.9575. WiSA Technologies started taking pre-orders for WiSA E multichannel audio development kits.
• NextDecade Corporation NEXT gained 35% to $6.93 after the company announced it has entered into framework agreements with Global Infrastructure Partners and TotalEnergies to support the development of the Rio Grande LNG project.
• Ideanomics, Inc. IDEX rose 27.6% to $0.1177.
• Inventiva S.A. IVA shares climbed 22.3% to $4.49 after the company announced its Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD achieved its primary efficacy endpoint.
• Greenidge Generation Holdings Inc. GREE gained 21.3% to $1.93.
• Coherent Corp. COHR surged 17% to $50.13.
• Leju Holdings Limited LEJU rose 16.9% to $2.9699.
• IPG Photonics Corporation IPGP climbed 16.1% to $135.92. Raymond James upgraded IPG Photonics from Market Perform to Outperform and announced a $170 price target.
• Akoya Biosciences, Inc. AKYA gained 15.5% to $7.57.
• Gossamer Bio, Inc. GOSS surged 13.6% to $1.3410.
• Microvast Holdings, Inc. MVST jumped 12.7% to $1.7698.
• T2 Biosystems, Inc. TTOO shares gained 11.7% to $0.0696. T2 Biosystems recently reported a clinical collaboration with Vanderbilt University Medical Center to implement and evaluate the T2Bacteria panel for clinical use.
• Nikola Corporation NKLA rose 9.4% to $1.00 after jumping over 19% on Tuesday.
• Matterport, Inc. MTTR gained 8.8% to $3.1898. Matterport announced Genesis, a generative AI initiative to transform how buildings are designed, built, and managed.
• Accelerate Diagnostics, Inc. AXDX climbed 8.7% to $0.8586. Accelerate Diagnostics recently posted downbeat quarterly results.
• NightHawk Biosciences, Inc. NHWK shares gained 7.8% to $0.67.

Losers

• Tenon Medical, Inc. TNON shares dipped 56.5% to $0.2693 after it priced its public offering of $5.6M at $0.56 per unit.
• Advanced Health Intelligence Ltd. AHI fell 39.3% to $0.9102 after dropping over 37% on Tuesday. Advanced Health Intelligence said it will undertake AUD$5 million private placement.
• Cineverse Corp. CNVS shares fell 37.1% to $2.24 after the company reported pricing of $8 million public offering.
• IperionX Limited IPX dropped 29.2% to $9.35. IperionX shares climbed over 100% on Tuesday after the company announced it will produce titanium components for the Ford Motor Company.
• IO Biotech, Inc. IOBT fell 23.8% to $1.63 after the company increased the enrolled patients in Phase 3 trial to 380, potentially accelerating the time to reach the primary end point of progression free survival.
• FLJ Group Limited FLJ dropped 22.7% to $0.3095.
• MicroVision, Inc. MVIS fell 22.4% to $4.9401 after the company filed for a mixed shelf offering.
• Eastside Distilling, Inc. EAST fell 22.1% to $4.8505 after the company disclosed business and financial updates.
• MIND Technology, Inc. MIND declined 20.6% to $0.6208 following wider-than-expected quarterly loss.
• Singularity Future Technology Ltd. SGLY fell 18.1% to $0.42.
• SMX (Security Matters) Public Limited Company SMX dropped 16.6% to $0.6407. SMX achieved 100% year-to-date growth in commercialization driven by client adoption & transformation across industries.
• agilon health, inc. AGL dropped 14.2% to $18.08.
• Allogene Therapeutics, Inc. ALLO dropped 13.3% to $4.94. Allogene Therapeutics reported the departure of CFO Eric T. Schmidt.
• Mullen Automotive, Inc. MULN dipped 13.2% to $0.279.
• Humana Inc. HUM fell 13.1% to $445.64. Shares of several health insurers traded lower following comments from UnitedHealth Group CEO highlighting an increase in elevated volumes of non-urgent surgeries, which has increased fears of higher costs for insurers.
• agilon health, inc. AGL dropped 12.2% to $18.45. Evercore ISI Group initiated coverage on Agilon Health with an In-Line rating and announced a price target of $22.5.
• Bruush Oral Care Inc. BRSH fell 12% to $0.3346 after jumping over 22% on Tuesday.
• Altisource Asset Management Corporation AAMC declined 11.8% to $54.35. Altisource Asset Management reported favorable ruling from New York Appellate Court.
• Logitech International S.A. LOGI shares dropped 11.8% to $56.35. Logitech said President and CEO Bracken Darrell will be departing to pursue another opportunity.
• Ocular Therapeutix, Inc. OCUL fell 11.5% to $5.62.
• Affirm Holdings, Inc. AFRM fell 9.6% to $16.93 after BTIG initiated coverage on the stock with a Sell rating and announced a $10 price target.
• Centene Corporation CNC dropped 7.7% to $64.11. Shares of several health insurers traded lower following comments from UnitedHealth Group CEO highlighting an increase in elevated volumes of non-urgent surgeries, which has increased fears of higher costs for insurers.
• UnitedHealth Group Incorporated UNH shares declined 7.1% to $456.70 after the company's CEO highlighted an increase in elevated volumes of non-urgent surgeries, which has increased fears of higher costs for insurers.
• Icahn Enterprises L.P. IEP fell 7% to $28.40.
• Cinemark Holdings, Inc. CNK dropped 6.6% to $17.18. B. Riley Securities downgraded Cinemark from Buy to Neutral and lowered the price target from $21 to $20.
• Kura Oncology, Inc. KURA shares fell 5.3% to $12.05 after the company reported commencement of $100 million public offering of common stock and pre-funded warrants.
• RadNet, Inc. RDNT shares fell 5.2% to $31.21. Radnet priced an underwritten offering of 7.575 million shares at $29.75 per share, with gross proceeds of approximately $225 million.

Now Read This: Kroger Likely To Report Flat Q2 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts